OMDA
Omada Health, Inc.
$22.98
-0.02 (-0.09%)
At close · Jul 8
Market Cap
$1.40B
Shares
59,448,507
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$260.21M
+53.2%
FY2025
Net Income
-$12.78M
+72.9%
FY2025
Gross Margin
65.69%
+5.1pp
FY2025
Operating Margin
-4.6%
+21.1pp
FY2025
Diluted EPS
-$0.35
+94.3%
FY2025
Operating Cash Flow
$18.25M
+153.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|---|
| $322M – $330M | $283.3M | $260.21M | $169.8M | $122.78M | |
| — | $95.56M | $89.27M | $66.92M | $52.81M | |
| — | $187.73M | $170.94M | $102.88M | $69.97M | |
| — | — | 65.69% | 60.59% | 56.99% | |
| — | $44.57M | $40.68M | $35.92M | $33.74M | |
| — | $96.66M | $90.04M | $68.05M | $66.25M | |
| — | $54.85M | $52.18M | $42.56M | $35.98M | |
| — | — | $1.9M | $2M | $2M | |
| — | — | $5.49M | $4.8M | $4.45M | |
| — | $196.09M | $182.91M | $146.53M | $135.97M | |
| — | -$8.36M | -$11.97M | -$43.65M | -$66M | |
| — | — | -4.6% | -25.71% | -53.75% | |
| — | — | -$6.48M | -$38.85M | -$61.55M | |
| — | $1.48M | $2.53M | $4.51M | $4.71M | |
| — | $6.59M | $5.31M | $805K | $5.78M | |
| — | $2.06M | -$806K | -$3.48M | -$1.51M | |
| — | -$6.3M | -$12.78M | -$47.14M | -$67.51M | |
| — | $0 | $0 | $0 | $0 | |
| — | -$6.3M | -$12.78M | -$47.14M | -$67.51M | |
| — | — | -4.91% | -27.76% | -54.98% | |
| — | -$6.3M | -$12.78M | -$47.14M | -$67.51M | |
| USD/shares | — | — | -$0.35 | -$6.11 | -$9.52 |
| USD/shares | — | — | -$0.35 | -$6.11 | -$9.52 |
| shares | — | — | 36.64M | 7.72M | 7.09M |
| shares | — | — | 36.64M | 7.72M | 7.09M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
31.40×
Health Information Services median 33.63×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Reportable Segment | $260,210,000 | $169,800,000 | $122,784,000 |
By Product & Service (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Service | $241,043,000 | $157,789,000 | $114,531,000 |
| Hardware | $19,167,000 | $12,011,000 | $8,253,000 |